2004N-0133 - Part 11 Public Meeting; June 11, 2004
FDA Comment Number : EC4
Submitter : Mr. Peter Robertson Date & Time: 05/11/2004 06:05:24
Organization : AstraZeneca
International Industry
Category :
Issue Areas/Comments
GENERAL
GENERAL
I wish to submit the attached abstract for consideration for oral presentation at the public meeting:

Issue areas: Narrow scope and risk based management